Genetic Control of Obesity and Gut Microbiota Composition in Response to High-Fat, High-Sucrose Diet in Mice by Parks, Brian W. et al.
Genetic Control of Obesity and Gut Microbiota Composition in
Response to High-Fat, High-Sucrose Diet in Mice
Brian W. Parks1,*, Elizabeth Nam1, Elin Org1, Emrah Kostem2, Frode Norheim1,3, Simon T.
Hui1, Calvin Pan4, Mete Civelek1, Christoph D. Rau1, Brian J. Bennett1,5, Margarete
Mehrabian1, Luke K. Ursell6, Aiqing He7, Lawrence W. Castellani1, Bradley Zinker8, Mark
Kirby8, Thomas A. Drake9, Christian A. Drevon3, Rob Knight6,10, Peter Gargalovic11, Todd
Kirchgessner11, Eleazar Eskin2,4, and Aldons J. Lusis1,4,*
1Department of Medicine/Division of Cardiology, David Geffen School of Medicine, University of
California, Los Angeles California 90095, USA
2Department of Computer Science, University of California, Los Angeles, California 90095, USA
3Department of Nutrition, Institute of Basic Medical Sciences, Faculty of Medicine, University of
Oslo, Norway
4Department of Human Genetics, David Geffen School of Medicine, University of California, Los
Angeles, California 90095, USA
5Department of Genetics, University of North Carolina, Chapel Hill 27599, USA
6Department of Chemistry and Biochemistry, University of Colorado Boulder, Colorado 80309,
USA
7Department of Applied Genomics, Bristol-Myers Squibb, Princeton, New Jersey 08543, USA
8Department of Metabolic Diseases-Diabetes Drug Discovery, Bristol-Myers Squibb, Princeton,
New Jersey 08543, USA
9Department of Pathology and Laboratory Medicine, University of California, Los Angeles, CA
90095, USA
10Howard Hughes Medical Institute, Boulder, CO, 80309, USA
11Department of Atherosclerosis Drug Discovery, Bristol-Myers Squibb, Princeton, New Jersey
08543, USA
SUMMARY
© 2013 Elsevier Inc. All rights reserved.
*Corresponding Authors: Aldons J. Lusis, Ph.D., Depts. of Human Genetics, Microbiology, Immunology and Molecular Genetics,
and Medicine, University of California, Los Angeles, 650 Charles E. Young Dr. South, A2-237 Center for Health Sciences, Los
Angeles, CA 90095-1679, jlusis@mednet.ucla.edu, Phone: 310-825-1359, Fax: 310-794-7345; Brian W. Parks, Ph.D., Dept. of
Medicine, Cardiology, University of California, Los Angeles, 675 Charles E. Young Dr. South, MRL 3220, Los Angeles, CA 90095,
Phone: 310-825-1595, Fax: 310-794-7345, bparks@mednet.ucla.edu.
Accession Numbers
All microarray data from this study are deposited in the NCBI GEO (http://www.ncbi.nlm.nih.gov/geo/) under the accession number
XXX.
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our
customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of
the resulting proof before it is published in its final citable form. Please note that during the production process errors may be
discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
NIH Public Access
Author Manuscript
Cell Metab. Author manuscript; available in PMC 2014 January 08.
Published in final edited form as:










Obesity is a highly heritable disease driven by complex interactions between genetic and
environmental factors. Human genome-wide association studies (GWAS) have identified a
number of loci contributing to obesity; however, a major limitation of these studies is the inability
to assess environmental interactions common to obesity. Using a systems genetics approach, we
measured obesity traits, global gene expression, and gut microbiota composition in response to a
high-fat/high-sucrose (HF/HS) diet of more than 100 inbred strains of mice. Here we show that
HF/HS feeding promotes robust, strain-specific changes in obesity that is not accounted for by
food intake and provide evidence for a genetically determined set-point for obesity. GWAS
analysis identified 11 genome-wide significant loci associated with obesity traits, several of which
overlap with loci identified in human studies. We also show strong relationships between
genotype and gut microbiota plasticity during HF/HS feeding and identify gut microbial
phylotypes associated with obesity.
INTRODUCTION
The dramatic increase in obesity during the past few decades is tightly associated with the
increase in obesity-related complications, such as type 2 diabetes, heart disease, and cancer.
Energy-rich diets containing high levels of fat and refined carbohydrates along with
sedentary lifestyles are believed to be the most significant environmental factors
contributing to this epidemic (Finucane et al., 2011; Malik et al., 2010). Understanding the
genetic and environmental interactions contributing to obesity is thus crucial for developing
novel therapies and preventive strategies. Human genome-wide association studies (GWAS)
and studies of rare monogenic forms of obesity, as well as biochemical studies with cells
and animal models, have identified relevant genes and pathways important in obesity;
however, given the complexity of the obesity phenotype and the small amount of variance
that can be explained by known obesity alleles, it is clear that much remains to be
discovered (Attie and Scherer, 2009; Bouchard et al., 1990; Knights et al., 2011; Sandholt et
al., 2010; Speakman et al., 2011).
Obesity is strongly heritable in humans, with estimates ranging from 50 to 90% (Barsh et al.,
2000; Stunkard et al., 1986). Large human GWAS explain less than 3% of this heritable
component and environmental interactions with diet composition likely add significant
complexity to such studies (Kilpelainen et al., 2011; Sonestedt et al., 2009; Speliotes et al.,
2010). Indeed, long-term overfeeding in monozygotic twins promotes striking within-pair
similarities in fat mass gain, demonstrating that gene-by-diet interactions may be highly
heritable and have a large impact on obesity (Bouchard et al., 1990). In addition to host
genetic contributions, the microbial community within the gut has been shown to influence
obesity in humans and mice (Turnbaugh et al., 2009a; Turnbaugh et al., 2006). The gut
microbiota is a transmissable trait and can undergo dynamic population shifts with varied
dietary composition (Benson et al., 2010; Turnbaugh et al., 2009b; Yatsunenko et al., 2012).
Obese subjects have an altered gut microbiota compared to lean individuals, which may be
an important contributing factor to the obesity epidemic (Turnbaugh et al., 2009a). To date,
very little is known about the genetic basis of gene-by-diet and gut microbiota-diet
interactions to common obesogenic factors, such as the consumption of energy-rich diets.
Identification of genes contributing to complex traits, such as obesity, in mice has been
hampered by the poor mapping resolution of traditional genetic crosses (Bhatnagar et al.,
2011; Burrage et al., 2010; Dokmanovic-Chouinard et al., 2008; Ehrich et al., 2005b; Flint et
al., 2005; Lawson et al., 2011; York et al., 1999; Zhang et al., 1994). Based on the genome
sequencing of many mouse strains, the identification of millions of single nucleotide
polymorphisms (SNPs) (Keane et al., 2011), and the development of an algorithm that
corrects for population structure in association analysis (Kang et al., 2008), we recently
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developed a systems genetics resource in the mouse capable of high resolution genome-wide
association mapping (Bennett et al., 2010). This resource, termed the Hybrid Mouse
Diversity Panel (HMDP) is composed of more than 100 commercially available mouse
strains and is ideal for systems-level analyses of gene-by-environment interactions.
Association-based mapping approaches in rodents have recently been reviewed (Flint and
Eskin, 2012).
Employing a systems genetics approach in the mouse, we integrated physical, molecular
traits, and gut microbiota composition data in response to an energy-rich diet. Using GWAS
rather than quantitative trait locus (QTL) analyses, we obtained biologically meaningful
genetic mapping, such that several of the genetic loci identified contained between 1-3
genes, comparable to human GWAS. These genes were prioritized using expression
quantitative trait locus (eQTL) analysis and we were able to show a significant overlap
between mouse and human GWAS loci. We measured the change in fat dynamically, at five
different points following high-fat/high-sucrose (HF/HS) feeding, providing strong evidence
for a genetically controlled body fat set-point. Our use of inbred mice strains also enabled
detailed analysis of the relationship between gut microbiota composition, obesity traits, and
diet. Overall, gene-by-diet interactions were highly reproducible and pervasive, providing a
partial explanation for the failure of human studies to explain a larger fraction of the genetic
basis of obesity. Our results indicate that mouse GWAS and systems genetics analyses
provide a powerful method to complement human studies and to address factors, such as
gene-by-diet interactions, that would be difficult to study directly in humans.
RESULTS
Robust Variation in Gene-by-Diet Interactions
To assess gene-by-diet interactions common to obesity, male mice were fed ad libitum a HF/
HS diet that represents a typical fast food diet, in terms of fat and refined carbohydrates
(32% kcal from fat and 25% kcal from sucrose). Mice were maintained on a chow diet (6%
kcal from fat) until 8 weeks of age and subsequently placed on a HF/HS diet for 8 weeks.
Body fat percentage was assessed by magnetic resonance imaging (MRI) every two weeks
and food intake was monitored for a period of one week at the middle of the study timeline
(study schematic shown in Figure 1A). Altogether, about 100 inbred strains of male mice
were studied, with an average of 6 mice of each strain (Table S1).
A wide distribution in body fat percentage was observed in male mice before HF/HS feeding
(Figures 1B). Dietary responses, as assessed by the body fat percentage increase during HF/
HS feeding, varied widely among the strains (Figures 1C and S1). Although many strains
exhibited a significant increase in body fat percentage throughout the study timeline, their
individual responses differed significantly, from no change to a 200% increase in body fat
percentage within the first two weeks (Figures 1C). Most strains responded during the first 4
weeks of HF/HS feeding and did not accumulate additional fat during the remainder of the
study, suggesting an upper set-point whereby continued body fat percentage growth is
resisted (Figure 1C) (Speakman et al., 2011). The large effect of the HF/HS feeding on fat
accumulation was confirmed with age-matched (16 weeks old) male mice (Table S2) fed a
chow diet, which displayed similar body fat percentage to male mice before the HF/HS diet
intervention (Figure S1A). Additionally, comparison of individual male strains maintained
on a chow diet or fed a HF/HS diet for 8 weeks showed an average increase in body fat
percentage from 0 to more than 600% (Figure S1B).
We observed high heritability of about 80% for body fat percentage across the study
timeline (Table 1). Changes in body fat percentage after HF/HS feeding were also highly
heritable (>70%), suggesting that dietary responses are strongly controlled by genetics. Our
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results are consistent with the heritability estimates for body mass index (BMI) and obesity
in humans (Barsh et al., 2000; Stunkard et al., 1986) and emphasize the importance of
genetics in controlling obesity traits, such as gene-by-diet interactions.
Other Factors Contributing to Dietary Responsiveness
Over-consumption of high-calorie, energy-rich foods is a key environmental factor
contributing to the global obesity epidemic (McCaffery et al., 2012). To understand the
relationship between food intake and obesity, food intake was monitored and found to range
from 2-5 grams per mouse per day. Total food intake per day was significantly correlated
with body weight and lean mass (Figures 1D and E). In contrast, body fat percentage and
body fat percentage change after 4 weeks of HF/HS feeding showed little to no correlation
with food intake (Figures 1F and G). This suggests that factors outside of food intake largely
underlie the variation of obesity and fat mass gain between the strains in response to HF/HS
feeding.
To further define the contribution of energy consumption to the differences in fat
accumulation, we performed in vivo metabolic chamber analyses of five inbred strains that
are the progenitors of the recombinant inbred strains (and therefore contribute importantly to
the overall genetic component) on chow diet. Significant strain differences were observed in
total food intake, activity, heat production, and utilization of different energy substrates, as
indicated by respiratory exchange ratio (RER) (Figures S2A, B, C, and D), all of which can
influence dietary responses and subsequent fat accumulation.
GWAS and Systems Genetics Analysis
Association analysis was performed using about 100,000 informative SNPs, spaced
throughout the genome, with efficient mixed model association (EMMA) adjusting for
population structure (Kang et al., 2008). The threshold for genome-wide significance was
based on simulation and permutations, as previously described (Farber et al., 2011). This
approach has been validated using transgenic analyses and by comparison with linkage
analysis (Bennett et al., 2010). Altogether, 11 genome-wide significant loci were found to be
associated with obesity traits (Table 2). Loci averaged 500 kb to 2 Mb in size and in most
cases contained 1 to 20 genes within a linkage disequilibrium (LD) block, an improvement
of more than an order of magnitude as compared to traditional linkage analysis in mice
which has a resolution of 10 to 20 Mb (Flint et al., 2005).
In order to help identify candidate genes at loci, global expression analyses of epididymal
adipose tissue in male mice (16 weeks old) fed a chow diet were carried out to determine
genetic regulation and correlation between gene expression and body fat percentage. The
loci controlling transcript levels in adipose tissue were mapped using EMMA and are
referred to as expression Quantitative Trait Loci (eQTL). Loci are termed “cis” if the locus
maps within 1 Mb of the gene encoding the transcript and “trans” if the locus is outside 1
Mb. Overall, 3,960 cis and 4,496 trans eQTL were identified to have a genome-wide
significance threshold (cis threshold: p < 1.4 × 10−3 and trans threshold: p < 6.1 × 10−6)
(Figure S3A). Cis regulation indicates a potential functional genomic variation within or
near a gene that significantly influences gene expression of a given gene. For example, Fto,
the most widely replicated gene in human GWAS for obesity shows a strong cis eQTL in the
adipose tissue of mice (Figure S5D), indicating genetic variation of this gene.
Global gene expression in epididymal adipose tissue was correlated with body fat
percentage in chow fed mice (top 50 genes shown in Table S3). Many genes known to play
a vital role in adipose biology showed significant correlations with body fat percentage.
Leptin is a key adipose-derived hormone correlating with adipose tissue mass (Ioffe et al.,
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1998) and is strongly correlated (r = 0.75; p < 2.2 × 10−16) with body fat percentage (Figure
2A). Other important adipose tissue genes, such as Sfrp5 (Ouchi et al., 2010) (r = 0.76; p <
2.2 × 10−16), Chrebp (Herman et al., 2012) (r = −0.57; p = 2.28 × 10−9) and Tmem160 (r =
0.71; p = 4.21 × 10−16), a recently identified gene from a human GWAS for body mass
index (BMI) (Speliotes et al., 2010), were also found to be highly correlated with body fat
percentage (Figure 2B, S3B and S3C).
Genetic Control of Obesity and Dietary Responsiveness
Most strains in the study showed a striking increase in body fat percentage within the first
two weeks of HF/HS feeding (Figure 1C). Association analysis with body fat percent
increase after 2 weeks of HF/HS feeding identified genome-wide significant loci on
Chromosomes 2 and 6 (Table 2 and Figure S4A). The chromosome 2 locus (rs13476804; p
= 2.95 × 10−6) contains one gene within the LD block, Sptlc3, which has been implicated in
biogenesis of sphingolipids (Demirkan et al., 2012; Hornemann et al., 2009). The locus on
chromosome 6 contains 11 genes within LD and the peak single nucleotide polymorphism
(SNP), (rs13478690; p = 2.8 × 10−7) is 33.5kb upstream of Klf14, a primary candidate
causal gene at this locus (Table 2 and Figure S4B). Klf14 has previously been identified in
human GWAS for type 2 diabetes (Voight et al., 2010) and has recently been shown to be a
master regulator of gene expression in adipose tissue (Small et al., 2011). Our results
support a role of Klf14 in regulating changes in adipose tissue and indicate that Klf14 may
also regulate dietary interactions.
Eight genome-wide significant loci were associated with body fat percentage growth after 8
weeks of HF/HS feeding (Table 2 and Figure 2C). The most significant signal (rs31849980;
p = 1.4 × 10−8) maps to chromosome 1 and has genome-wide significant SNPs spanning a 5
Mb region with 60 genes within LD (Table 2). A primary candidate gene within this locus is
Degs1, a fatty acid desaturase involved in the metabolism of important bioactive
sphingolipids (Ternes et al., 2002). Degs1 expression in adipose tissue of chow fed male
mice is strongly correlated (within top 10 genes) with body fat percentage (r = 0.7; p = 1.3 ×
10−15) (Figure 3E). Previous linkage studies in mice have identified distal chromosome 1 as
contributing importantly to obesity (Chen et al., 2008) and our results greatly refine this
region and suggest Degs1 as a high-confidence candidate gene in the locus, although given
the size of the locus multiple genes may be contributing to the signal.
Of the eight loci associated with body fat percent growth after 8 weeks of HF/HS feeding
both loci on chromosomes 16 and 18 contained genes with genome-wide cis eQTL and
strong expression correlation with body fat percentage in epididymal adipose tissue (Figure
3C). The peak SNP at chromosome 18 (rs30078681; p = 4.3 × 10−8) contained 26 genes
within LD and one gene, Npc1 was previously identified in a human GWAS for obesity
(Meyre et al., 2009). Gene expression analysis of Npc1 indicated a strong negative
correlation with body fat percentage (r = −0.4; p = 1.5 × 10−5) (Figure S3D) and the
presence of a genome-wide significant cis eQTL (Figure S5A). Genomic sequence analysis
indicated multiple non-synonymous coding variations within the Npc1 gene (Keane et al.,
2011). Furthermore, Npc1 heterozygous knockout mice exhibit increased obesity on a high
fat diet, but not on a chow diet (Jelinek et al., 2010), confirming the importance of Npc1 in
regulating dietary interactions. The chromosome 16 locus (rs3148854; p = 9.0 × 10−8) has 8
genes within LD of the genome-wide significant SNPs and one gene in this region, Cbr1
(Figure 3D) is highly expressed in adipose tissue and is negatively correlated (r = −0.5; p =
1.6 × 10−7) with obesity (Figure 2F). Furthermore, Cbr1 has a cis eQTL (p = 1.1 × 10−4)
(Figure 5B) and contains multiple non-synonymous coding variants (Keane et al., 2011).
Cbr1 reduces carbonyl compounds via NADPH-dependent oxidoreductase activity and
through its glutathione (GSH)-binding site Cbr1 can act on GSH-conjugated molecules and
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play a role in controlling oxidative stress (Bateman et al., 2008), an important component of
obesity (Furukawa et al., 2004).
The loci for body fat growth following 8 weeks of HF/HS feeding also contained genes with
known links to adipose biology and metabolism. The locus on chromosome 5 (rs13478388;
p = 1.5 × 10−7) contains several C-X-C motif chemokine genes within LD. Cxcl5 is one of
the genes in this cluster (Figure S4C), and expression of Cxcl5 is increased in adipose tissue
of obese human subjects (Chavey et al., 2009). Cxcl5 contains non-synonymous coding
polymorphisms and an alternative splice site among multiple mouse strains (Keane et al.,
2011), making Cxcl5 a strong candidate at the chromosome 5 locus. Similarly, the
significant SNP at chromosome 3 (rs29982345; p = 9.9 × 10−7) is within 1 Mb of three
amylase genes, Amy2b, Amy2a5, and Amy1 (Figure S4D). Amylases play a critical role in
the breakdown of polysaccharides to sugars and targeting amylases has been suggested as a
potential method for treating obesity (Barrett and Udani, 2011). The significant peak on
chromosome 11 (rs29417268; p = 2.8 × 10−7) has 11 genes within LD and one gene, Glp2r,
plays an important role in intestinal homeostasis and feeding behavior (Guan et al., 2012).
We also observed genome-wide significant loci for dietary response at two positions on
chromosome 18 (rs13483184; p = 2.6 × 10−07 and rs29628302; p = 2.6 × 10−7) with no
obvious candidate genes (Table 2).
In addition to loci influencing dietary response, there was one genome-wide significant
locus at chromosome 7 associated with body fat percentage after 8 weeks of HF/HS feeding.
This locus was gene-rich and contained 113 genes within LD of the peak SNP (rs13479513;
p = 6.7 × 10−7). Two genes at this locus, Atp2a1 and Apob48r have previously been
identified in human GWAS for BMI (Speliotes et al., 2010; Thorleifsson et al., 2009).
Furthermore, this locus contains Sephs2, a strong candidate gene with both a significant cis
eQTL (p = 1.4 × 10−4) and an exceptionally strong negative correlation with body fat
percentage (r = 0.68; p = 2.0 × 10−14) (Figures S3E and S5C). Sephs2 is an evolutionarily
conserved protein that is essential for production of selenocysteine (Xu et al., 2007), a key
amino acid found in a diverse group of proteins with roles in the pathology of metabolic
syndrome and diabetes (Rayman, 2012).
Conservation of Human and Mouse Metabolic Loci
A comparison of the genes/loci identified in our study with GWAS genes for human obesity
and BMI revealed significant overlap (p = 4.0 × 10−4) (described in Experimental
Procedures). In addition to genome-wide significant loci, we analyzed significant human
GWAS genes in our association results and identified suggestive associations near Opcml
and Sorl1 (Table 3). Both Opcml and Sorl1 have been found in large human GWAS for
visceral adipose/subcutaneous adipose ratio and waist circumference, respectively (Fox et
al., 2012; Smith et al., 2010). Our results demonstrate that genes associated with obesity and
BMI in humans show functional variation in mice and are associated with dietary
interactions and obesity.
Contributions of Gut Microbiota to Obesity
A number of recent studies have implicated gut microbiota in metabolic and cardiovascular
diseases (Turnbaugh et al., 2006; Vijay-Kumar et al., 2010; Wang et al., 2011). In order to
investigate the genetic contributions to the gut microbiome and their relationship to obesity
and dietary responses we examined the gut microbiota composition and distribution in
strains after chow and HF/HS feeding. Since the microbiome is highly affected by
environmental factors, all mice in the study were bred in the same facility and each strain
was maintained in separate cages. We observed significant phylum-level shifts in the gut
microbiota composition after HF/HS feeding (Figure 3A). The shifts between the two
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dominant phyla Bacteroidetes and Firmicutes after HF/HS feeding (Figure 3A and Table
S4), are consistent with previous reports (Turnbaugh et al., 2009b). Principal Coordinates
Analysis (PCoA) of unweighted UniFrac (similar results for weighted UniFrac shown in
Figure S6B) (Lozupone and Knight, 2005) distances detected two clear clusters
corresponding to the two dietary conditions (Figure 3B), suggesting that HF/HS feeding
dramatically alters gut microbial communities across a variety of genetic backgrounds.
Compared to mice on a chow diet the HF/HS fed mice had greater abundance of several
genera classified to order Clostridales in Phyla Firmicutes and lower abundances of
Bacteroidetes, classified to family Porphyromonadaceae (41% chow vs 18% HF/HS,
p=4.36×10−11). In total we identified 17 genera whose abundance was significantly changed
by diet (p<0.01) (Figure 3C, and Table S4). Interestingly, the abundance of Akkermansia
genera of the Verrucomicrobia phylum explains much of the unweighted UniFrac distance
clusters on PCoA plots in HF/HS diet (Figures S6C and S6D).
Robust effects of diet on the gut microbiota are well documented and recent evidence
indicates that the gut microbiota constitute a complex polygenic trait under genetic
regulation (Benson et al., 2010; McKnite et al., 2012; Qin et al., 2012). Consistent with the
idea that the gut microbiota is influenced by genetic factors, we observed a strong effect of
genetic background on the composition and plasticity of the gut microbiota after HF/HS
feeding. Some strains showed large shifts in all major phyla, while other strains had little
fluctuation in their gut microbiota after HF/HS feeding (Figure 4A). Additionally, Procrustes
analysis was used to compare the relative orientation of matched strains after HF/HS and
chow feeding and confirmed that the plasticity of gut microbial community is highly
individualized (Figure 4B). Taken together, these results demonstrate a profound effect of
HF/HS feeding on gut microbiota and show the strong influences of host genetics on
influencing the plasticity of the gut microbiota in response to altered dietary compositions.
To test the relationship between obesity, dietary responsiveness, and gut microbiota
composition we analyzed all 11 genome-wide significant loci with the abundances of
specific gut phylotypes. Only the chromosome 3 locus (rs29982345), which is associated
with body fat growth after 8 weeks of HF/HS feeding showed a significant enrichment (p =
0.0033) of the genera Enterobacteriaceae (phylum Proteobacteria). This region of
chromosome 3, which contains three amylase genes, may therefore contribute to both
dietary responsiveness and gut microbiota composition. We also examined the relationship
between specific gut phylotypes and obesity traits and observed a modest but statistically
significant negative correlation with the abundance of the genera Akkermansia (phylum
Verrucomicrobia) and body fat percentage growth after 8 weeks of HF/HS feeding (Figure
4C). Furthermore, body fat percentage growth after HF/HS feeding was positively correlated
with the relative abundances of Lactococcus from phylum Firmicutes (Figure 4D) and with
the genera Allobaculum (phylum Bacteroidetes) (Figure 4E). Additional studies are
warranted to validate the connections of these specific gut microbiota and dietary
interactions.
DISCUSSION
Our results have led to several findings about the genetic control of responses to energy-rich
diets consumed by an increasing fraction of the world’s population. Although biochemical
and genetic studies have revealed important regulators of body fat, including feedback
pathways that modulate food intake and energy expenditure, these studies have not revealed
how common genetic variation controls these processes. Human GWAS studies have been
successful at identifying many loci controlling measures such as body mass index, but they
have been unable to examine gene-by-environment interactions. Classic linkage studies in
mice, on the other hand, have been able to partially address issues such as dietary
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responsiveness (Ehrich et al., 2005b), but have been hindered by poor mapping resolution,
and, thus, only a handful of genes have been identified (Buchner et al., 2012; Dokmanovic-
Chouinard et al., 2008; Ehrich et al., 2005a; York et al., 1999; Zhang et al., 1994). Our
results add to this body of knowledge in several important ways. First, the improved
mapping resolution enabled us to identify several candidate genes for gene-by-environment
interactions in obesity. Second, because we examined obesity traits in a dynamic way,
studying the mice following dietary challenge at multiple time points, we were able to
provide strong evidence for the concept of a biologic set-point. Third, we have integrated the
obesity traits with global adipose transcript levels and gut microbiota composition. Fourth,
our results emphasize the importance of gene-by-environment interactions, with important
implications for an understanding of the overall genetic architecture of obesity. Finally, our
results provide the basis of a systems genetics resource for obesity traits that can be
expanded to include multiple biologic scales using metabalomics, proteomics, and
epigenetics. In particular it will be of interest to examine behavioral and neurological
differences among the strains as they relate to obesity traits.
Using association rather than linkage, we were able to obtain biologically significant
mapping data, as several of the loci identified for the response to a HF/HS diet contained
between 1-3 genes, comparable to human GWAS results. Altogether, we examined only
about 800 mice, much fewer than the tens of thousands examined in human GWAS. It is
likely that power is greatly increased in mice, as compared to humans, because of the ability
to accurately monitor the phenotypes (body fat, food intake) and control the environment.
Also, for the loci containing larger numbers of candidates, examination of transcript levels
in adipose tissue and access to complete DNA sequence information, allowed us to prioritize
candidates. Indeed, several of the genes at such loci (Npc1 and Glp2r) have already been
studied using transgenic approaches with results consistent with our findings (Guan et al.,
2012; Jelinek et al., 2010).
Several different models have been developed to understand how genes and environment
combine to regulate body fat. However, only limited studies have addressed the genetic
basis of gene-by-environment interactions in obesity. The dual intervention point model
postulates an upper and lower limit where genetic factors become dominant, and between
which there is only weak genetic regulation (Speakman et al., 2011). Our results strongly
support this concept, because after 4 weeks of HF/HS feeding most mouse strains reach an
upper limit where there is no further increase in body fat (Figure 1). Thus, there must be
strong genetic factors that resist continued fat accumulation beyond a certain point. Clearly,
this set-point varies widely in the population; some strains have already achieved the set-
point level on a chow diet whereas a few strains continue to accumulate fat throughout the 8
week feeding period, suggesting that the set-point mechanism is disrupted. It is noteworthy
that obesity prevalence appears to be leveling off in developed countries, which is also
consistent with the idea of a set-point (Flegal et al., 2012). Based on our data (Table 1) and a
monozygotic twin study (Bouchard et al., 1990), acute body fat changes in response to an
obesogenic environment are under strong genetic regulation, although this may be part of
the same pathway that determines the set-point. Our data also show that food intake is only
modestly correlated with obesity and dietary responsiveness, and indicates energy
expenditure may be a likely mechanism contributing to the obesity set-point. Further
metabolic studies of strains at the extremes will be required to confirm the effect of energy
expenditure on obesity set-points.
The experimental design of our study, involving inbred strains of mice, allowed us to study
the gut microbiota composition of the mice both on a chow and HF/HS diet. The HF/HS diet
clearly influenced gut microbiota composition in all of the 52 strains examined on both
chow and the HF/HS diet (Figure 3). Shifts in gut microbiota composition and diversity in
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response to dietary changes are similar to those previously noted in both human (Ley et al.,
2006; Turnbaugh et al., 2009b) and mouse studies (Ley et al., 2005; Turnbaugh et al., 2006).
Our data indicate that host genetic factors influence gut microbiota plasticity in response to
diet; however, since the gut microbiota can vary significantly even in well-controlled
cohorts we cannot exclude the possibility that other factors could partly explain the observed
differences. We observed significant relationships between gut microbiota and metabolic
traits (Figure 4C, 4D, 4E). The results are consistent with the concept that gut microbiota
contribute to systemic functions and common diseases (Clemente et al., 2012). Future
studies in the HMDP have the potential to test the roles of specific gut microbiota using
transplantation and cross-fostering to systematically examine the relationship between
genetic background, diet, and gut microbiota composition.
Recent successes in human GWAS for common diseases have yielded many genetic loci,
but in most instances they have revealed only a very small fraction of the estimated
heritability (Lander, 2011). While it is likely that some of the “missing heritability” will be
found in rare variants in the population, our results, and those from other studies in animal
models (Burrage et al., 2010; Lawson et al., 2011; Shao et al., 2008) suggest that genetic
interactions are likely to have important contributions. Clearly, human studies have limited
ability to identify gene-by-environment or gene-by-gene interactions (Zuk et al., 2012), and
our results suggest that GWAS in mice will provide a powerful complement to human
studies. A key feature of our experimental design is that genetically identical mice can be
studied under multiple environmental conditions. Also, the greatly improved resolution of
association as compared to classical linkage studies in mice greatly facilitates gene
identification and mechanistic understanding. The substantial overlap of our study with
human GWAS for obesity traits suggests that at least for metabolic disorders, the mouse is
highly relevant and that natural variations of the two species affect shared pathways.
Because the inbred strains of the HMDP are permanent, data obtained about the strains is
cumulative, allowing integration with previous results. The data compiled here provides a
basis for further genetic studies of obesity-related traits in mice. It will be of interest, for
example, to examine additional intermediate phenotypes, such as protein and metabolite
levels, in the same set of strains, and to relate these to the obesity traits using association
mapping, correlation, and modeling. In this study, we examined transcript levels in adipose
tissue, and the composition of gut microbiota and in the future it would be valuable to
examine transcript levels in other relevant tissues, such as the hypothalamus, liver, and
muscle, as well as protein, metabolite levels, and epigenetic markers. Moreover, traits such
as epigenetic variation and gut microbiota composition can be tested for effects on obesity-
related traits in this set of strains.
EXPERIMENTAL PROCEDURES
Animals
All mice were obtained from The Jackson Laboratory and were bred at University of
California, Los Angeles to generate mice used in this study. Mice were maintained on a
chow diet (Ralston Purina Company) until 8 weeks of age when they were given a high-fat,
high-sucrose diet (Research Diets-D12266B) with the following composition, 16.8 % kcal
protein, 51.4 % kcal carbohydrate, 31.8 % kcal fat. Age-matched control male mice were fed
a chow diet (18% kcal fat) for 16 weeks. A complete list of the strains included in our study
is included in Supplemental Tables 1 and 2. The animal protocol for the study was approved
by the Institutional Care and Use Committee (IACUC) at University of California, Los
Angeles.
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Association Analysis and Heritability Calculations
We performed the association testing of each SNP using a linear mixed model, which
accounts for the population structure among the n animals using the following model (Kang
et al., 2008):
,where μ is the mean, β is the allele effect of the SNP, x is the (nx1) vector of observed
genotypes of the SNP, u is the random effects due to genetic relatedness with 
and e is the random noise with . K denotes the identity-by-state (IBS) kinship
matrix estimated from all the SNPs, I denotes the (nxn) identity matrix and 1n is the (nx1)
vector of ones. We estimated  and  using restricted maximum likelihood (REML), and
computed p-values using the standard F-test to test the null hypothesis β = 0. Genome-wide
significance threshold and genome-wide association mapping are determined as the family-
wise error rate as the probability of observing one or more false positives across all SNPs for
phenotype. We ran 100 different sets of permutation tests and parametric boot strapping of
size 1,000, and observed that the mean and standard error of the genome-wide significance
threshold at the family-wise error rate of 0.05 were 3.9 × 10−6 ± 0.3 × 10−6, and 4.0 × 10−6
± 0.3 × 10−6, respectively. A detailed explanation of the analyses is provided in Bennett et.
al. (Bennett et al., 2010). Linkage disequilibrium (LD) was determined by calculated
pairwise r2 SNP correlations for each chromosome. Approximate LD boundaries were
determined by visualizing r2 > 0.8 correlations in MATLAB (MathWorks)
Heritability (in the narrow-sense) is defined as the phenotypic variance explained by
additive genetic effects and is computed using the following model (Yang et al., 2010):
We estimated  and  using REML and calculated the heritability (h2) for each trait as
follows:
where tr(.) is the matrix trace and .
Body Composition Analysis
Animals were measured for total body fat mass and lean mass by magnetic resonance
imaging (MRI) using Bruker Minispec with software from Eco Medical Systems, Houston,
TX (Taicher et al., 2003). All animals in the study were measured at 0, 2, 4, 6, and 8 weeks
of HF/HS feeding.
Assessment of food intake
After 4 weeks of HF/HS feeding, food intake was monitored for 5 days. Ninety to 100 grams
of food was weighed and put in the food hopper, after 24 hours food was weighed, and then
weighed again after 24 hours. The procedure was repeated again with fresh food, and a total
of 4 × 24 hour period total food weight consumed was calculated by subtracting food
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weights; grams per mouse was then calculated by dividing average total food weight
consumed in 4 × 24 hour periods by number of mice in cage.
In vivo metabolism assessment
Metabolic rate, activity, food and water consumption were assessed using a Columbus
Instruments Comprehensive Lab Animal Monitoring System (CLAMS; Columbus
Instruments, Columbus, OH) equipped with sub-systems for open circuit indirect
calorimetry, and monitoring of activity, feeding, and drinking. Detailed methods for in vivo
metabolism assessment provided in Supplementary Experimental Procedures.
Gut Microbiota Analysis
Microbial community composition was assessed by pyrosequencing 16S rRNA genes
derived from the cecal samples of chow diet and HF/HS diet animals. All mice used in the
study were bred at UCLA to ensure uniform environmental conditions. Furthermore, strains
were individually housed within the same vivarium throughout the duration of the study. To
ensure comprehensive analysis we sequenced biological replicates on all mice included in
the study. Biological replicates were carried out on all mice included in the study. For mice
fed a HF/HS diet we sequenced a range of 2 to 5 mice per strain, with an average of 3 mice
per strain (n=339 male mice from 110 strains). Chow diet mice were sequenced by pooling 2
to 4 mice per strain, with an average of 2 per strain (n=108 male mice from 52 strains). We
also sequenced technical replicates on 8 mouse strains (5 strains on chow diet and 3 on HF/
HS diet) and observed high reproducibility of UniFrac analysis between technical replicates
(Figure S6A). Detailed methods for gut microbiota analysis provided in Supplementary
Experimental Procedures.
Adipose RNA isolation and global gene expression analysis
Flash frozen epididymal adipose samples from male mice (16 weeks old) maintained on a
chow diet were weighed and homogenized in Qiazol (Qiagen) and RNA isolated according
to the manufacturer’s protocol using RNeasy columns (Qiagen). Isolated RNA (2 mice per
strain as indicated in Supplementary Table 2) was analyzed for global gene expression using
Affymetrix HT_MG430A arrays and was filtered as described (Bennett et al., 2010).
Expression eQTL analysis
GWAS for gene expression was performed using EMMA and defined as cis if peak SNP
mapped within 1 Mb of gene position and trans if mapped outside (cis threshold: p < 1.4 ×
10−3 and trans threshold: p < 6.1 × 10−6).
Statistics
Correlations were calculated using the biweight midcorrelation, which is robust to outliers
(Wilcox, 2005). Overlap p-value between mouse and human GWAS genes was calculating
using hypergeometric cumulative distribution function in MATLAB (MathWorks) using
pval = 1 - hygecdf(x,M,K,N), where x = total number of genes in genome, M = total number
of genes identified in mouse and humans, K = number of genes identified in obesity and
BMI human GWAS, N = number of genes identified in mouse obesity traits.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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• Detailed analysis of diet-induced obesity in more than 100 inbred mouse strains
• Identification of 11 genetic loci associated with obesity and dietary
responsiveness
• Significant overlap between mouse loci with human GWAS loci for obesity
• Strain-specific shifts in gut microbiota composition in response to dietary
intervention
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Figure 1. Natural Variation in Gene-by-Diet Interactions
(A) Schematic of study design with indicated time points for HF/HS feeding (red), MRI
(blue), food intake monitoring (yellow), and end of study (red). MRI, magnetic resonance
imaging.
(B) Body fat percentage in male mice (108 strains) before (red) and after (blue) 8 weeks of
HF/HS feeding. Error bars (black) represent standard error of the mean (SEM)
(C) Bi-weekly percent body fat percentage increase in male mice with indicated body fat
percentage increase after 8 weeks of HF/HS feeding.
(D-G) Correlation of food intake (grams/day/mouse) with body weight (D), lean mass (E),
body fat percentage – 4 weeks on HF/HS diet (F), and body fat percentage growth – 0 to 4
weeks (G), regression line (red). r, biweight midcorrelation, p, p-value.
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Figure 2. Genetic Control of Dietary Responses to HF/HS Feeding
(A-B) Correlation of epididymal adipose gene expression of Leptin (Lep) (A) and Sfrp5 (B)
with body fat percentage in male HMDP mice fed a chow diet, regression line (red). r,
biweight midcorrelation, p, p-value.
(C) Manhattan plot showing the significance (−log10 of p) of all SNPs and percent body fat
percentage increase after 8 weeks of HF/HS feeding in male HMDP mice. Candidate genes
for genome-wide significant loci are indicated above genome-wide significant loci.
Genome-wide significant threshold (red) of p=4.1 × 10−06 is indicated.
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(D) Locus plot for genome-wide significant association at chromosome 16qC4 with
approximate LD block (shaded in grey) and genome-wide significant SNPs (yellow) with
the peak SNP (red).
(E-F) Correlation of epididymal adipose gene expression of Degs1 (E) and Cbr1 (F) with
body fat percentage in male HMDP mice fed a chow diet, regression line (red). r, biweight
midcorrelation, p, p-value.
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Figure 3. Robust Shifts in Gut Microbiota Composition After HF/HS Feeding
(A) Relative abundances of the different phyla after chow diet and HF/HS feeding (average
among 52 matched strains).
(B) Principal Coordinates Analysis (PCoA) plot of the unweighted UniFrac distances. Each
circle representing a different mice strain is colored according to the dietary conditions.
PC1, PC2 and PC3 values for each mouse sample are plotted; percent variation explained by
each PC is shown in parentheses.
(C) Linear Discriminant Analysis (LDA) coupled with effect size measurements identifies
the most differentially abundant taxons between chow and HF/HS diets. HF/HS diet
enriched taxa are indicated with a positive LDA score (green), and taxa enriched in normal
chow diet have a negative score (red). Only taxa meeting an LDA significant threshold >2
are shown.
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Figure 4. Plasticity of Gut Microbiota is Strain-Specific
(A) Gut Microbiota phyla shift in 52 strains after HF/HS feeding for 8 weeks indicated by
shift in percent composition of indicated phylum.
(B) Procrustes analysis of the same strains on chow diet and the HF/HS diet are linked with
a bar. The unweighted UniFrac distances between the diets varies across strains, but are in
general long, highlighting the shifts in microbial composition in response to diet.
(C-E) Correlation of relative abundance of Akkermansia (A), Lactococcus (B), and
Allobaculum (C) with body fat percentage increase from 0 to 8 weeks in male mice fed a
HF/HS diet, regression line (red), r, biweight midcorrelation, p, p-value.
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Table 1
Heritability Estimates for Obesity and Dietary Responsiveness
Trait Heritability (%)
Body Fat Percentage – 0 weeks on HF/HS diet 80
Body Fat Percentage – 2 weeks on HF/HS diet 82
Body Fat Percentage – 4 weeks on HF/HS diet 83
Body Fat Percentage – 6 weeks on HF/HS diet 83
Body Fat Percentage – 8 weeks on HF/HS diet 85
Body Fat Percentage growth - 0 to 2 weeks
Body Fat Percentage growth - 0 to 4 weeks 63
Body Fat Percentage growth - 0 to 6 weeks 67
Body Fat Percentage growth - 0 to 8 weeks 73
Body fat percentage growth calculated by quantifying the percentage increase of body fat after beginning HF/HS diet. Heritability calculated as
described in experimental procedures.
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